Search research articles
Contact Us
Filters
Showing results (181-190 of 497) with videos related to
Page
of 50
Sort By:
International Journal of Pharmaceutics
|
September 11, 2015
Size-dependent specific targeting and efficient gene silencing in peritoneal macrophages using a pH-sensitive cationic liposomal siRNA carrier
Hideki Matsui, Yusuke Sato, Hiroto Hatakeyama, et al.
Molecular Pharmaceutics
|
April 19, 2018
Reducing the Cytotoxicity of Lipid Nanoparticles Associated with a Fusogenic Cationic Lipid in a Natural Killer Cell Line by Introducing a Polycation-Based siRNA Core
Takashi Nakamura, Koharu Yamada, Yuki Fujiwara, et al.
Biomaterials
|
April 30, 2013
The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells
Golam Kibria, Hiroto Hatakeyama, Noritaka Ohga, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
July 23, 2013
A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication
Nazir Hossen, Kazuaki Kajimoto, Hidetaka Akita, et al.
Biological & Pharmaceutical Bulletin
|
December 3, 2014
Comparative study of the sensitivities of cancer cells to doxorubicin, and relationships between the effect of the drug-efflux pump P-gp
Golam Kibria, Hiroto Hatakeyama, Kosuke Akiyama, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 16, 2017
Nano-sized drug carriers: Extravasation, intratumoral distribution, and their modeling
Joseph W Nichols, Yu Sakurai, Hideyoshi Harashima, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 26, 2017
Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects
Naoya Miura, Hidetaka Akita, Naho Tateshita, et al.
Scientific Reports
|
August 7, 2019
The silencing of indoleamine 2,3-dioxygenase 1 (IDO1) in dendritic cells by siRNA-loaded lipid nanoparticles enhances cell-based cancer immunotherapy
Rikito Endo, Takashi Nakamura, Kyoko Kawakami, et al.
Biological & Pharmaceutical Bulletin
|
October 12, 2016
Liver-Specific Silencing of Lipin1 Reduces Fat Mass as Well as Hepatic Triglyceride Biosynthesis in Mice
Kazuaki Kajimoto, Erina Suemitsu, Yusuke Sato, et al.
Advanced Drug Delivery Reviews
|
December 3, 2015
Heterogeneity of tumor endothelial cells and drug delivery
Kyoko Hida, Nako Maishi, Yu Sakurai, et al.
Page
of 50
Search research articles
Search
Showing results (181-190 of 497) with videos related to
Sort By:
Page
of 50
International Journal of Pharmaceutics
|
September 11, 2015
Size-dependent specific targeting and efficient gene silencing in peritoneal macrophages using a pH-sensitive cationic liposomal siRNA carrier
Hideki Matsui, Yusuke Sato, Hiroto Hatakeyama, et al.
Molecular Pharmaceutics
|
April 19, 2018
Reducing the Cytotoxicity of Lipid Nanoparticles Associated with a Fusogenic Cationic Lipid in a Natural Killer Cell Line by Introducing a Polycation-Based siRNA Core
Takashi Nakamura, Koharu Yamada, Yuki Fujiwara, et al.
Biomaterials
|
April 30, 2013
The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells
Golam Kibria, Hiroto Hatakeyama, Noritaka Ohga, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
July 23, 2013
A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication
Nazir Hossen, Kazuaki Kajimoto, Hidetaka Akita, et al.
Biological & Pharmaceutical Bulletin
|
December 3, 2014
Comparative study of the sensitivities of cancer cells to doxorubicin, and relationships between the effect of the drug-efflux pump P-gp
Golam Kibria, Hiroto Hatakeyama, Kosuke Akiyama, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 16, 2017
Nano-sized drug carriers: Extravasation, intratumoral distribution, and their modeling
Joseph W Nichols, Yu Sakurai, Hideyoshi Harashima, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 26, 2017
Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects
Naoya Miura, Hidetaka Akita, Naho Tateshita, et al.
Scientific Reports
|
August 7, 2019
The silencing of indoleamine 2,3-dioxygenase 1 (IDO1) in dendritic cells by siRNA-loaded lipid nanoparticles enhances cell-based cancer immunotherapy
Rikito Endo, Takashi Nakamura, Kyoko Kawakami, et al.
Biological & Pharmaceutical Bulletin
|
October 12, 2016
Liver-Specific Silencing of Lipin1 Reduces Fat Mass as Well as Hepatic Triglyceride Biosynthesis in Mice
Kazuaki Kajimoto, Erina Suemitsu, Yusuke Sato, et al.
Advanced Drug Delivery Reviews
|
December 3, 2015
Heterogeneity of tumor endothelial cells and drug delivery
Kyoko Hida, Nako Maishi, Yu Sakurai, et al.
Page
of 50